SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-057276
Filing Date
2023-12-04
Accepted
2023-12-04 17:25:08
Documents
2
Period of Report
2023-12-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 16994
2 POA DOCUMENT poa.txt EX-24 3018
  Complete submission text file 0001209191-23-057276.txt   21370
Mailing Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713
Business Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713 919.806.1074
CHIMERIX INC (Issuer) CIK: 0001117480 (see all company filings)

IRS No.: 330903395 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CHIMERIX, INC. 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713
Business Address
LaSpaluto Michelle (Reporting) CIK: 0002001106 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35867 | Film No.: 231464437